Titre : Inositol phosphates

Inositol phosphates : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cancer-Associated Fibroblasts
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inositol phosphates : Questions médicales les plus fréquentes", "headline": "Inositol phosphates : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inositol phosphates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-23", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inositol phosphates" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oses phosphates", "url": "https://questionsmedicales.fr/mesh/D013403", "about": { "@type": "MedicalCondition", "name": "Oses phosphates", "code": { "@type": "MedicalCode", "code": "D013403", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inositol 1,4,5-trisphosphate", "alternateName": "Inositol 1,4,5-Trisphosphate", "url": "https://questionsmedicales.fr/mesh/D015544", "about": { "@type": "MedicalCondition", "name": "Inositol 1,4,5-trisphosphate", "code": { "@type": "MedicalCode", "code": "D015544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.350" } } }, { "@type": "MedicalWebPage", "name": "Acide phytique", "alternateName": "Phytic Acid", "url": "https://questionsmedicales.fr/mesh/D010833", "about": { "@type": "MedicalCondition", "name": "Acide phytique", "code": { "@type": "MedicalCode", "code": "D010833", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Inositol phosphates", "alternateName": "Inositol Phosphates", "code": { "@type": "MedicalCode", "code": "D007295", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Adolfo Saiardi", "url": "https://questionsmedicales.fr/author/Adolfo%20Saiardi", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK. Electronic address: a.saiardi@ucl.ac.uk." } }, { "@type": "Person", "name": "Henning J Jessen", "url": "https://questionsmedicales.fr/author/Henning%20J%20Jessen", "affiliation": { "@type": "Organization", "name": "Institute of Organic Chemistry & CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Gabriel Schaaf", "url": "https://questionsmedicales.fr/author/Gabriel%20Schaaf", "affiliation": { "@type": "Organization", "name": "Department of Plant Nutrition, Institute of Crop Science and Resource Conservation, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany. gabriel.schaaf@uni-bonn.de." } }, { "@type": "Person", "name": "Debabrata Laha", "url": "https://questionsmedicales.fr/author/Debabrata%20Laha", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK." } }, { "@type": "Person", "name": "Stephen B Shears", "url": "https://questionsmedicales.fr/author/Stephen%20B%20Shears", "affiliation": { "@type": "Organization", "name": "Inositol Signaling Section, NIEHS, 111, Alexander Drive, Research Triangle Park, Durham, NC 27709, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.", "datePublished": "2023-03-06", "url": "https://questionsmedicales.fr/article/36890105", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.euo.2023.02.011" } }, { "@type": "ScholarlyArticle", "name": "Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance.", "datePublished": "2023-09-04", "url": "https://questionsmedicales.fr/article/37660643", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2023.115425" } }, { "@type": "ScholarlyArticle", "name": "Cancer-associated fibroblasts: tumor defenders in radiation therapy.", "datePublished": "2023-08-22", "url": "https://questionsmedicales.fr/article/37607935", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41419-023-06060-z" } }, { "@type": "ScholarlyArticle", "name": "Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts.", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37342322", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1194642" } }, { "@type": "ScholarlyArticle", "name": "Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.", "datePublished": "2024-03-15", "url": "https://questionsmedicales.fr/article/38491511", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12967-024-05085-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Oses phosphates", "item": "https://questionsmedicales.fr/mesh/D013403" }, { "@type": "ListItem", "position": 4, "name": "Inositol phosphates", "item": "https://questionsmedicales.fr/mesh/D007295" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inositol phosphates - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inositol phosphates", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inositol phosphates", "description": "Comment diagnostiquer un déséquilibre en inositol phosphates ?\nQuels tests sont utilisés pour évaluer les inositol phosphates ?\nLes inositol phosphates sont-ils mesurables dans les tissus ?\nY a-t-il des marqueurs spécifiques pour les inositol phosphates ?\nLes tests génétiques sont-ils utiles pour les inositol phosphates ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inositol phosphates", "description": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?\nLes inositol phosphates affectent-ils la santé mentale ?\nY a-t-il des signes physiques d'un déséquilibre ?\nLes inositol phosphates influencent-ils le métabolisme ?\nPeut-on observer des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inositol phosphates", "description": "Comment prévenir les déséquilibres en inositol phosphates ?\nLes suppléments sont-ils nécessaires pour la prévention ?\nY a-t-il des habitudes de vie à adopter ?\nLes consultations médicales sont-elles importantes ?\nLes facteurs environnementaux influencent-ils les niveaux ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inositol phosphates", "description": "Quels traitements existent pour les déséquilibres en inositol phosphates ?\nLes médicaments peuvent-ils aider avec les inositol phosphates ?\nY a-t-il des thérapies alternatives pour les inositol phosphates ?\nComment les changements alimentaires aident-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inositol phosphates", "description": "Quelles complications peuvent survenir avec des déséquilibres ?\nLes inositol phosphates sont-ils liés à des maladies chroniques ?\nY a-t-il des risques pour la santé reproductive ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications psychologiques sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inositol phosphates", "description": "Quels sont les facteurs de risque pour les déséquilibres ?\nL'âge influence-t-il les niveaux d'inositol phosphates ?\nLes maladies métaboliques sont-elles un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Cancer-Associated+Fibroblasts&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un déséquilibre en inositol phosphates ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent mesurer les niveaux d'inositol phosphates dans le corps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les inositol phosphates ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests biochimiques et les analyses de métabolites urinaires sont courants." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils mesurables dans les tissus ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent être effectuées pour évaluer les niveaux dans les tissus." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les inositol phosphates ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme l'IP3 peuvent indiquer des déséquilibres dans la signalisation cellulaire." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les inositol phosphates ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à identifier des troubles métaboliques liés aux inositol phosphates." } }, { "@type": "Question", "name": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles de l'humeur et problèmes métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Les inositol phosphates affectent-ils la santé mentale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être liés à des troubles de l'humeur comme la dépression." } }, { "@type": "Question", "name": "Y a-t-il des signes physiques d'un déséquilibre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des troubles de la peau ou des problèmes digestifs peuvent apparaître." } }, { "@type": "Question", "name": "Les inositol phosphates influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans la régulation du métabolisme lipidique et glucidique." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs et de la mémoire peuvent être liés à des déséquilibres." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres en inositol phosphates ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Les suppléments sont-ils nécessaires pour la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments peuvent être bénéfiques, surtout en cas de carence alimentaire." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier et la gestion du stress peuvent aider à maintenir l'équilibre." } }, { "@type": "Question", "name": "Les consultations médicales sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent aider à détecter des déséquilibres précocement." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les niveaux ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Quels traitements existent pour les déséquilibres en inositol phosphates ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments d'inositol et des modifications alimentaires peuvent être recommandés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider avec les inositol phosphates ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments psychotropes peuvent influencer les niveaux d'inositol phosphates." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives pour les inositol phosphates ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la phytothérapie peuvent être explorées, mais nécessitent des études." } }, { "@type": "Question", "name": "Comment les changements alimentaires aident-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits et légumes peut améliorer les niveaux d'inositol." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon les besoins individuels et les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des déséquilibres ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques, neurologiques et psychologiques peuvent se développer." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils liés à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être associés à des maladies comme le diabète." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la santé reproductive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent affecter la fertilité et la santé reproductive." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en cas de déséquilibre prolongé." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines peuvent être réversibles avec un traitement approprié et un suivi." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les déséquilibres ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre, le stress et des antécédents familiaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux d'inositol phosphates ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux peuvent diminuer avec l'âge, augmentant le risque de déséquilibre." } }, { "@type": "Question", "name": "Les maladies métaboliques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme le diabète peuvent affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie inactif peut contribuer à des déséquilibres en inositol phosphates." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut perturber le métabolisme des inositol phosphates." } } ] } ] }

Sources (10000 au total)

Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.

Bladder cancer (BLCA) is a highly prevalent tumour and a health problem worldwide, especially among men. Recent work has highlighted the relevance of the tumour microenvironment (TME) in cancer biolog... To review the role of CAFs in BLCA biology and provide an understanding of CAF origin, subtypes, markers, and phenotypic and functional characteristics to improve patient management.... A PubMed search was performed to review manuscripts published using the terms "cancer associated fibroblast" and "bladder cancer" or "urothelial cancer". All abstracts were reviewed, and the full cont... CAFs have been studied less extensively in BLCA than in other tumours. Thanks to new techniques, such as single-cell RNA-seq and spatial transcriptomics, it is now possible to accurately map and molec... Current knowledge of BLCA CAFs and the TME is being increasingly applied to improve BLCA therapy. There is a need to acquire a deeper understanding of CAF biology in BLCA.... Tumour cells are surrounded by nontumoural cells that contribute to the determination of the behaviour of cancers. Among them are cancer-associated fibroblasts. The "neighbourhoods" established throug...

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.

Ovarian cancer (OC) is distinguished by its aggressive nature and the limited efficacy of current treatment strategies. Recent studies have emphasized the significant role of cancer-associated fibrobl... Employing sophisticated machine learning techniques on bulk transcriptomic datasets, we identified fibroblast growth factor 7 (FGF7), derived from CAFs, as a potential oncogenic factor. We investigate... Our findings indicate that higher FGF7 levels correlate with advanced tumor stages, increased vascular invasion, and poorer prognosis. CAFs-derived FGF7 significantly enhanced OC cell proliferation, m... Neutralizing FGF7 in the medium or inhibiting HIF-1α signaling reversed the effects of FGF7-mediated EMT, emphasizing the dependence of FGF7-mediated EMT on HIF-1α activation. These findings suggest t...

Cancer-associated fibroblast-dependent and -independent invasion of gastric cancer cells.

Cancer cells are known to exhibit a cancer-associated fibroblast (CAF)-dependent invasive mode in the presence of CAFs. The purpose of this study was to investigate whether intrinsic factors of gastri... We observed dynamic movement of CAFs, and cancer cells, by time-lapse imaging of 2-D and 3-D collagen invasion models, and evaluated invasion modes of gastric cancer cell lines (MKN-7, MKN-45, and HSC... When MKN-7 and MKN-45 cells were co-cultured with CAFs, CAFs first invade collagen matrix followed by cancer cells (CAF-dependent invasion), whereas HSC44PE cells invaded collagen matrix independent o... These results indicate that in presence of CAFs, gastric cancer cells exhibit both CAF-dependent and -independent modes of invasion, the determinants of which may depend on the intrinsic properties of...